23andMe's Pharma Deals Have Been the Plan All Along
By Megan Molteni,
Wired
| 08. 03. 2018
Since the launch of its DNA testing service in 2007, genomics giant 23andMe has convinced more than 5 million people to fill a plastic tube with half a teaspoon of saliva. In return for all that spit (and some cash too), customers get insights into their biological inheritance, from the superficial—do you have dry earwax or wet?—to mutations associated with disease. What 23andMe gets is an ever-expanding supply of valuable behavioral, health, and genetic information from the 80 percent of its customers who consent to having their data used for research.
So last week’s announcement that one of the world’s biggest drugmakers, GlaxoSmithKline, is gaining exclusive rights to mine 23andMe’s customer data for drug targets should come as no surprise. (Neither should GSK’s $300 million investment in the company). 23andMe has been sharing insights gleaned from consented customer data with GSK and at least six other pharmaceutical and biotechnology firms for the past three and a half years. And offering access to customer information in the service of science has been 23andMe’s business plan all along, as WIRED noted...
Related Articles
By Sarah Mervosh, The New York Times | 02.17.2019
A Minnesota man was eating a hot dog at a hockey game when, the authorities said, he wiped his mouth with a napkin and tossed the remains in the trash.
It was the moment cold-case investigators had been waiting for....
By Antonio Regalado, MIT Technology Review | 02.11.2019
As many people purchased consumer DNA tests in 2018 as in all previous years combined, MIT Technology Review has found.
Surging public interest in ancestry and health—propelled by heavy TV and online marketing—was behind a record year for sales of...
By Allison Lewis, Daily News | 02.08.2019
If you think clandestine DNA dragnets and secret databases are things of science fiction, I have some upsetting news.
From the same law enforcement playbook that brought you stop-and-frisk comes the latest form of racial profiling and policing: the knock-and-spit....
By Michael J. Joyner and Nigel Paneth, Stat | 02.07.2019
Twenty years ago, Dr. Francis Collins, who was then director of the National Center for Human Genome Research, made rosy predictions in his Shattuck Lecture about the health benefits sure to flow from the Human Genome Project. His paper on...